Morocco medicine price database

APROVEL

IRBESARTAN

Public price

218,00 MAD

Reimbursement base

218,00 MAD

Active substance

IRBESARTAN

Reimbursable

What is this medicine?

APROVEL contains IRBESARTAN. Its clinical use depends on the approved indication for this substance and the pharmaceutical form available in Morocco.

Verified summary

IRBESARTAN, COMPRIME PELLICULE, 300 MG, 1 BOITE 28 COMPRIME

Common uses

General use context: oral form, with use determined by the doctor or pharmacist according to the situation.

Class

ANTAGONISTE DE L'ANGIOTENSINE II - P

Availability note

Reimbursable

Hospital price

136,30 MAD

Strength

300 MG

Form

COMPRIME PELLICULE

Presentation

1 BOITE 28 COMPRIME

Type

P

Therapeutic class

ANTAGONISTE DE L'ANGIOTENSINE II

This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.

Price history

Reference price recorded since 2017-12-18: 218,00 MAD

Available presentations and strengths

Medicines with the same active substance